Nyumbani IPHASE DS8201a

IPHASE DS8201a

Maelezo Fupi:

DS-8201a, also known as trastuzumab deruxtecan (T-DXd), is an antibody-drug conjugate (ADC) designed for the treatment of HER2-positive cancers. It combines a HER2-targeting monoclonal antibody (similar to trastuzumab) with a potent topoisomerase I inhibitor (deruxtecan) as the cytotoxic payload. The drug delivers chemotherapy directly to cancer cells expressing HER2, improving efficacy while limiting damage to normal cells.

WASILIANA NA SASA Ongeza kwenye gari la ununuzi

Maelezo ya Bidhaa

Lebo za Bidhaa

Ufafanuzi wa bidhaa DS-8201a, pia inajulikana kama trastuzumab deruxtecan (T-DXd), ni kingamwili-unganishi wa dawa (ADC) iliyoundwa kwa ajili ya matibabu ya HER2-kansa chanya. Inachanganya HER2-kingamwili monokloni inayolenga (sawa na trastuzumab) na kizuizi chenye nguvu cha topoisomerase I (deruxtecan) kama mzigo wa cytotoxic. Dawa hiyo hutoa chemotherapy moja kwa moja kwa seli za saratani zinazoonyesha HER2, kuboresha ufanisi huku ikizuia uharibifu wa seli za kawaida.

Kategoria:
Cathepsin
Kipengee NO.:
015200.01
Ukubwa wa kitengo:
50uL,2mg/mL
Tishu:
N/A
Aina:
N/A
Hali ya uhifadhi na usafiri:
Hifadhi kwa -70°C. Barafu kavu hutolewa.